Definitive Contract 75F40120C00172
Award Date
9/28/20
Potential Completion Date
1/11/24
Potential Value
$1.6M
Federal Agency
Food and Drug Administration
Awardee
Virginia Commonwealth University
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Richmond, VA 23284, USA
Solicitation Procedures
Basic Research
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Health and Human Services, Food and Drug Administration awarded a firm-fixed price definitive contract to Virginia Commonwealth University (VCU) to evaluate relationships between in vitro nasal spray characterization test metrics for bioequivalence and nasal deposition in silico and in vitro. The contract has a potential value of $1,136,057.48 and a completion date of July 30, 2021. VCU, a public research university located in Richmond, Virginia, has a broad range of federal...
This $4,236,731 definitive contract was awarded by the National Institute on Drug Abuse (NIDA), a civilian agency, to Virginia Commonwealth University (VCU) for preclinical medications discovery and abuse liability testing services. The contract supports NIDA's Addiction Treatment Discovery Program, under which VCU will evaluate potential pharmacotherapies for drug use disorders in rodents and primates, and conduct abuse liability testing of new drugs using behavioral pharmacology models. This...
The Department of Health and Human Services Food and Drug Administration awarded a $1.2 million definitive contract to Vidoori for office of new drugs, requirements and testing support. Under this contract, Vidoori will provide labor hours to support the FDA's testing and evaluation of new pharmaceutical products from September 2020 through March 2022. The place of performance is in Silver Spring, Maryland. No set aside designation or subcontractors were indicated. This support aligns with the...
This federal contract award from the Food and Drug Administration (FDA) to Battelle Memorial Institute, a nonprofit research and development organization, is for investigating the effects of nicotine pouch flavors on abuse liability in smokeless tobacco users. The $1,923,145.00 firm fixed-price delivery order has a period of performance ending on May 30, 2026. The award does not have a set-aside designation. Battelle has subcontracted with Montrose Environmental Group, Inc., an environmental...
This is a firm fixed price contract awarded by the Department of Health and Human Services (HHS) Food and Drug Administration (FDA) to the Virginia Department of Agriculture and Consumer Services (VDACS), a U.S. state government entity. The $254,362.42 contract is for food inspections to be performed in Richmond, VA. No set-aside was used. Through this and other federal contracts, VDACS has secured over $5 million from agencies like the FDA and USDA's Food Safety and Inspection Service to...
The Department of Health and Human Services' Food and Drug Administration awarded a Firm Fixed Price Definitive Contract to Uppsala Universitet, an educational institution, for the evaluation and development of model-based bioequivalence analysis strategies. The $574,726.00 contract, which does not have a set-aside designation, was awarded on April 10, 2017 with a completion date of September 1, 2020. The contractor specializes in scientific and research services related to the development and...
This $607,510 federal contract was awarded by the Food and Drug Administration (FDA) to the University of North Carolina at Chapel Hill (UNC-CH) to evaluate data from smart pump usage in health systems across the Midwest. The contract aims to study ways to reduce preventable medication errors by minimizing work distractions. This contract was awarded under the FDA's Broad Agency Announcement on regulatory science and innovation, and is not set aside for any specific business type. UNC-CH is...
The U.S. Food and Drug Administration (FDA) awarded a $4,825 firm fixed price definitive contract to the Virginia Department of Agriculture and Consumer Services (VDACS), a U.S. state government entity, for the "2011 Virginia Tissue Contract." This contract, which did not use a set-aside, was for the delivery of services from August 31, 2011 to August 31, 2012. VDACS has been awarded numerous federal contracts and grants from agencies such as the U.S. Department of Agriculture (USDA)...
This is a $1,337,028.39 firm-fixed-price contract awarded by the Food and Drug Administration (FDA) to the Virginia State Board of Health (VA SBOH) for the VA Mammography Quality Standards Act (MQSA) program. The contract, which runs through March 2028, is not set aside for any specific business type. The VA SBOH, a state government entity, will be responsible for ensuring proper equipment, training, and procedures at mammography facilities across Virginia through this contract. The VA SBOH...
Duke University Office of Research Administration Division was awarded a $274,413 definitive contract by the Department of Health and Human Services Food and Drug Administration to conduct a study using electronic health records to identify and assess adverse events for biologic therapies. The contract aims to develop and validate methodological approaches under the agency's Broad Agency Announcement for the Advanced Research and Development of Regulatory Science, which seeks proposals to...